Premature Infant Clinical Trials

Find Premature Infant Clinical Trials Near You

Near Infrared Spectroscopy (NIRS) Monitoring as an Early Predictor of Acute Kidney Injury (AKI) in a Vulnerable Neonatal Intensive Care Unit (NICU) Population

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The primary objective of this study is to describe the pattern of renal tissue oxygen saturation (SrSO2) using near-infrared spectroscopy (NIRS) in premature infants \<30 weeks gestational age. The secondary objective of this study is to evaluate prenatal and postnatal risk factors for acute kidney injury (AKI) in premature infants \<30 weeks gestational age. The investigators will also compare various rates of complications including death, length-of-stay, and prolonged duration of mechanical ventilation, among others.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 5 months
Maximum Age: 7 months
Healthy Volunteers: t
View:

• Any neonate less than 30 weeks in gestational age

• Willingness and capacity of both adult parents/guardians to sign consent

Locations
United States
New York
NYU Langone Health
RECRUITING
New York
Contact Information
Primary
Jordan Nelson, MD
Jordan.nelson@nyulangone.org
3478223664
Time Frame
Start Date: 2025-11
Estimated Completion Date: 2026-04-01
Participants
Target number of participants: 100
Treatments
Experimental: NICU patients born less than 30 weeks gestational age
All patients included in the study will be assigned to receive NIRS monitoring.
Related Therapeutic Areas
Sponsors
Leads: NYU Langone Health

This content was sourced from clinicaltrials.gov